Accera Inc., a company that makes a product labeled as “medical food” for the treatment of Alzheimer’s disease, has been sued in a class action in Florida that alleges Axona is a milkshake powder of common food ingredients with no proven benefits.
Plaintiffs Max and Sandra Goldfarb of Miami filed the suit against the Colorado-based healthcare firm in Florida’s Eleventh Judicial Circuit Court in Miami-Dade County on May 27, claiming Accera’s marketing of key brand Axona violates Florida’s Deceptive and Unfair Trade Practices Act (FDUTPA). Read the complaint here in Goldfarb et al. v. Accera Inc.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
